Disc Medicine, Inc. (IRON) vs Liquidia Corporation (LQDA)

A side-by-side comparison of Disc Medicine, Inc. and Liquidia Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IRON vs LQDA

growth of $100 · dividends reinvested · last 6y
IRON -38.5% (-7.8%/yr)LQDA +367.7% (+29.3%/yr)LQDA compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $100202120222023202420252026$61$468
IRON LQDA

IRON vs LQDA: by the numbers

  • •IRON is the larger company ($2.42B vs $2.39B market cap).
  • •LQDA is profitable (30.74% net margin) while IRON runs a net loss (0.00%).

Metrics side by side

Valuation

MetricIRONLQDA
P/E ratioN/A19.62
Forward P/EN/A10.81
P/S ratioN/A5.30
P/B ratio3.7512.24
EV / EBITDAN/A13.12
FCF yieldN/A2.53%

Profitability

MetricIRONLQDA
Gross margin0.00%92.48%
Operating margin0.00%-32.45%
Net margin0.00%30.74%
ROE-38.17%71.04%
ROIC-38.21%46.99%

Growth (annualized)

MetricIRONLQDA
Revenue CAGR (5Y)N/A128.77%
Total return CAGR (5Y)10.70%59.01%

Frequently asked

Is IRON or LQDA more profitable?
LQDA runs the higher net margin — IRON at 0.00% versus LQDA at 30.74%.
How have IRON and LQDA total returns compared?
Over the past 5 years, IRON delivered 10.70% and LQDA delivered 59.01% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.